ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical trials for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Hard-to-Treat bowel disease
Disease control Recruiting nowThis study is testing an experimental pill called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The main goals are to see if the pill is safe, if it helps control the disease, and how the body processes it. Participants will …
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug trial offers hope for Tough-to-Treat bowel disease
Disease control Recruiting nowThis study is testing an experimental drug called SHR-1139 in adults with moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. It aims to see if the drug can reduce symptoms and improve gut healing over a 60-week period. The trial is for people who haven't…
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC